Krishna Polu

Krishna Polu is currently serving as Executive in Residence at Bioqube Ventures, Chief Executive Officer at Commit Biologics, and Director of the Board of Directors at Sardona Therapeutics. With a strong background in the healthcare and biotechnology industry, Krishna has held various leadership roles at companies such as Equillium, Inc., Raptor Pharmaceuticals, and Frazier Lifesciences Acquisition Corporation. With a BA in Human Biology from Stanford University, an MD from The University of Texas Medical School at San Antonio, and additional certifications from Harvard Medical School and Stanford University Graduate School of Business, Krishna brings a wealth of knowledge and experience to the organizations Krishna is involved with.